Basilea reports strong 2020 financial results and significant progress in the clinical pipeline of its oncology assets

NEXT STORY
The global artificial cornea and corneal implant market is projected to reach USD 599 million by 2026 from USD 418 million in 2021, at a CAGR of 7.4% from 2021 to 2026
PREV STORY
Czech Republic First European Country to Grant National Authorisation for the Use of Telix’s Prostate Cancer Imaging Product
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Mateon Provides Update on OT-101

author_avatar
NASDAQ Market News

Promise to Expand Intermountain Healthcare, Primary Children’s Hospital Pediatric Behavioral Health Services Inspires $10 Million Gift

author_avatar
NASDAQ Market News

Longeveron to Release Third Quarter 2021 Financial Results and Hold Conference Call on November 12, 2021

author_avatar
NASDAQ Market News